| 000 | 01675 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516023544.0 | ||
| 264 | 0 | _c20110909 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1523-4681 | ||
| 024 | 7 |
_a10.1002/jbmr.341 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEastell, Richard | |
| 245 | 0 | 0 |
_aSafety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cJun 2011 |
||
| 300 |
_a1303-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 |
_aCathepsin K _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDemography |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xblood |
| 650 | 0 | 4 |
_aThiazolidines _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNagase, Shinichi | |
| 700 | 1 | _aOhyama, Michiyo | |
| 700 | 1 | _aSmall, Maria | |
| 700 | 1 | _aSawyer, James | |
| 700 | 1 | _aBoonen, Steven | |
| 700 | 1 | _aSpector, Tim | |
| 700 | 1 | _aKuwayama, Tomohiro | |
| 700 | 1 | _aDeacon, Steve | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 26 _gno. 6 _gp. 1303-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbmr.341 _zAvailable from publisher's website |
| 999 |
_c20589839 _d20589839 |
||